共 57 条
[11]
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design; pre-specified muscle and liver outcomes; and reasons for stopping study treatment.[J] ;Richard Haynes;Lixin Jiang;Jemma C Hopewell;Jing Li;Fang Chen;Sarah Parish;Martin J. Landray;Rory Collins;Jane Armitage;R. Collins;J. Armitage;C. Baigent;Z. Chen;M. Landray;Y. Chen;L. Jiang;T. Pedersen;M. Landray;L. Bowman;F. Chen;M. Hill;R. Haynes;C. Knott;K. Rahimi;J. Tobert;P. Sleight;D. Simp
[12]
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials[J] Cholesterol Treatment Trialists' (CTT) Collaborators The Lancet 2012,
[13]
Meta-Analysis of Statin Effects in Women Versus Men[J] William J. Kostis;Jerry Q. Cheng;Jeanne M. Dobrzynski;Javier Cabrera;John B. Kostis Journal of the American College of Cardiology 2012,
[14]
Serum lipids and lipoproteins in Chinese men and women.[J] Yang Wenying;Xiao Jianzhong;Yang Zhaojun;Ji Linong;Jia Weiping;Weng Jianping;Lu Juming;Shan Zhongyan;Liu Jie;Tian Haoming;Ji Qiuhe;Zhu Dalong;Ge Jiapu;Lin Lixiang;Chen Li;Guo Xiaohui;Zhao Zhigang;Li Qiang;Zhou Zhiguang;Shan Guangliang;He Jiang Circulation 2012,
[15]
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).[J] Reiner Zeljko;Catapano Alberico L;De Backer Guy;Graham Ian;Taskinen Marja-Riitta;Wiklund Olov;Agewall Stefan;Alegria Eduardo;Chapman M John;Durrington Paul;Erdine Serap;Halcox Julian;Hobbs Richard;Kjekshus John;Filardi Pasquale Perrone;Riccardi Gabriele;Storey Robert F;Wood David European heart
[16]
A meta-analysis of low-density lipoprotein cholesterol; non-high-density lipoprotein cholesterol; and apolipoprotein B as markers of cardiovascular risk.[J] Sniderman Allan D;Williams Ken;Contois John H;Monroe Howard M;McQueen Matthew J;de Graaf Jacqueline;Furberg Curt D Circulation. Cardiovascular quality and outcomes 2011,
[17]
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.[J] Mosca Lori;Benjamin Emelia J;Berra Kathy;Bezanson Judy L;Dolor Rowena J;Lloyd-Jones Donald M;Newby L Kristin;Piña Ileana L;Roger Véronique L;Shaw Leslee J;Zhao Dong;Beckie Theresa M;Bushnell Cheryl;D'Armiento Jeanine;Kris-Etherton Penny M;Fang Jing;Ganiats Theodore G;Gomes Antoinette S;Gracia Clarisa R;Haan Constance K;Jackson Elizabeth A;Judelson
[18]
Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis.[J] Bukkapatnam Radhika N;Gabler Nicole B;Lewis William R Preventive cardiology 2010,
[19]
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials[J] Cholesterol Treatment Trialists' (CTT) Collaboration The Lancet 2010,
[20]
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.[J] Mora Samia;Glynn Robert J;Hsia Judith;MacFadyen Jean G;Genest Jacques;Ridker Paul M Circulation 2010,